Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Guss J, Kazahaya K. Antibiotic-resistant Staphylococcus aureus in community-acquired pediatric neck abscesses. International Journal of Pediatric Otorhinolaryngology 2007;71(6):943–8.
Ossowski K, Chun RH, Suskind D, Baroody FM. Increased isolation of methicillin-resistant Staphylococcus aureus in pediatric head and neck abscesses. Archives of OtolarynÂgology-Head & Neck Surgery 2006;132(11):1176–81.
Thomason TS, Brenski A, McClay J, Ehmer D. The rising incidence of methicillin-resistant Staphylococcus aureus in pediatric neck abscesses. Otolaryngology and Head and Neck Surgery 2007;137(3):459–64.
Kaplan SL. Community-acquired methicillin-resistant Staphylococcus aureus infections in children. Seminars in Pediatric Infectious Diseases 2006;17(3):113–9.
Creech CB, 2nd, Kernodle DS, Alsentzer A, Wilson C, Edwards KM. Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. The Pediatric Infectious Disease Journal 2005;24(7):617–21.
Daum RS. Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. The New England Journal of Medicine 2007;357(4):380–90.
Coticchia JM, Getnick GS, Yun RD, Arnold JE. Age-, site-, and time-specific differences in pediatric deep neck abscesses. Archives of Otolaryngology-Head & Neck Surgery 2004;130(2):201–7.
Castaldo ET, Yang EY. Severe sepsis attributable to community-associated methicillin-resistant Staphylococcus aureus: an emerging fatal problem. The American Surgeon 2007;73(7):684–7; discussion 7–8.
Gonzalez BE, Martinez-Aguilar G, Hulten KG, et al Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 2005;115(3):642–8.
Malouin F, Bryan LE. Modification of penicillin-binding proteins as mechanisms of beta-lactam resistance. Antimicrobial Agents and Chemotherapy 1986;30(1):1–5.
de Lencastre H, Oliveira D, Tomasz A. Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power. Current Opinion in Microbiology 2007;10(5):428–35.
Moran GJ, Krishnadasan A, Gorwitz RJ, et al Methicillin-resistant S. aureus infections among patients in the emergency department. The New England Journal of Medicine 2006;355(7):666–74.
Nygaard TK, DeLeo FR, Voyich JM. Community-associated methicillin-resistant Staphylococcus aureus skin infections: advances toward identifying the key virulence factors. Current Opinion in Infectious Diseases 2008;21(2):147–52.
Klevens RM, Morrison MA, Nadle J, et al Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298(15):1763–71.
Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, Mongodin EF, Sensabaugh GF, Perdreau-Remington F. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006;367:731–9.
Strategies for clinical management of MRSA in the community: Summary of an experts’ meeting convened by the Centers for Disease Control and Prevention, 2006 (accessed at http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca.html).
Huskins WC. Interventions to prevent transmission of antimicrobial-resistant bacteria in the intensive care unit. Current Opinion in Critical Care 2007;13(5):572–7.
Le J, Lieberman JM. Management of community-associated methicillin-resistant Staphylococcus aureus infections in children. Pharmacotherapy 2006;26(12):1758–70.
Marcinak JF, Frank AL. Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children. Current Opinion in Infectious Diseases 2003;16(3):265–9.
Buescher ES. Community-acquired methicillin-resistant Staphylococcus aureus in pediatrics. Current Opinion in Pediatrics 2005;17(1):67–70.
Siberry GK, Tekle T, Carroll K, Dick J. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clinical Infectious Diseases 2003;37(9):1257–60.
Szczesiul JM, Shermock KM, Murtaza UI, Siberry GK. No decrease in clindamycin susceptibility despite increased use of clindamycin for pediatric community-associated methicillin-resistant Staphylococcus aureus skin infections. The Pediatric Infectious Disease Journal 2007;26(9):852–4.
Lee MC, Rios AM, Aten MF, et al Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. The Pediatric Infectious Disease Journal 2004;23(2):123–7.
Rajendran PM, Young D, Maurer T, et al Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant StaphyÂlococcus aureus infection. Antimicrobial Agents and Chemotherapy 2007;51(11):4044–8.
Rice HE, Frush DP, Farmer D, Waldhausen JH. Review of radiation risks from computed tomography: essentials for the pediatric surgeon. Journal of Pediatric Surgery 2007;42(4):603–7.
Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC. Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006. Clinical Infectious Diseases 2008;46(5):668–74.
Lentino JR, Narita M, Yu VL. New antimicrobial agents as therapy for resistant gram-positive cocci. European Journal of Clinical & Microbiology Infectious Diseases 2008;27(1):3–15.
Buenz EJ, Bauer BA, Johnson HE, et al Searching historical herbal texts for potential new drugs. British Medical Journal (Clinical Research ed.) 2006;333(7582):1314–15.
Buenz EJ, Bauer BA, Schnepple DJ, Wahner-Roedler DL, Vandell AG, Howe CL. A randomized Phase I study of Atuna racemosa: a potential new anti-MRSA natural product extract. Journal of Ethnopharmacology 2007;114(3):371–6.
Shinefield H, Black S, Fattom A, et al Use of a StaphyÂlococcus aureus conjugate vaccine in patients receiving hemodialysis. The New England Journal of Medicine 2002;346(7):491–6.
Capparelli EV, Bloom BT, Kueser TJ, et al Multicenter study to determine antibody concentrations and assess the safety of administration of INH-A21, a donor-selected human Staphylococcal immune globulin, in low-birth-weight infants. Antimicrobial Agents and Chemotherapy 2005;49(10):4121–7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science + Business Media, LLC
About this chapter
Cite this chapter
Valdez, T.A., Osborn, A.J. (2009). Methicillin-Resistant Staphylococcus aureus (MRSA) Infections of the Head and Neck in Children. In: Pereira, K., Mitchell, R. (eds) Pediatric Otolaryngology for the Clinician. Humana Press. https://doi.org/10.1007/978-1-60327-127-1_4
Download citation
DOI: https://doi.org/10.1007/978-1-60327-127-1_4
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-58829-542-2
Online ISBN: 978-1-60327-127-1
eBook Packages: MedicineMedicine (R0)